3-8627734-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001256748.3(SSUH2):c.638G>A(p.Arg213Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000478 in 1,610,402 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001256748.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SSUH2 | NM_001256748.3 | c.638G>A | p.Arg213Gln | missense_variant | 8/12 | ENST00000544814.7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SSUH2 | ENST00000544814.7 | c.638G>A | p.Arg213Gln | missense_variant | 8/12 | 2 | NM_001256748.3 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000177 AC: 27AN: 152228Hom.: 0 Cov.: 34
GnomAD3 exomes AF: 0.0000766 AC: 19AN: 248002Hom.: 0 AF XY: 0.0000745 AC XY: 10AN XY: 134166
GnomAD4 exome AF: 0.0000343 AC: 50AN: 1458174Hom.: 0 Cov.: 33 AF XY: 0.0000345 AC XY: 25AN XY: 725378
GnomAD4 genome AF: 0.000177 AC: 27AN: 152228Hom.: 0 Cov.: 34 AF XY: 0.000255 AC XY: 19AN XY: 74366
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 19, 2021 | The c.572G>A (p.R191Q) alteration is located in exon 8 (coding exon 5) of the SSUH2 gene. This alteration results from a G to A substitution at nucleotide position 572, causing the arginine (R) at amino acid position 191 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at